NCT06156761 2023-12-05
Mitoxantrone Hydrochloride Liposome Combined With Capecitabine in Patients With HER-2 Negative Advanced Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase NA Unknown
Clinical Trials
11 trialsNCT06015100 2023-08-29
Efficacy and Safety of Inetetamab Plus Pyrotiniband and Capecitabine in HER2-positive Metastatic Breast Cancer Patients With or Without Brain Metastasis
Xi'an International Medical Center Hospital
Phase NA Unknown
NCT04194957 2020-01-22
Alpe2U
The Netherlands Cancer Institute
Phase NA Unknown
NCT03821454 2019-02-01
CALORIE
Zhejiang Cancer Hospital
Phase NA Unknown
NCT03647514 2018-12-10
Abraxane Combined With Xeloda as Neo-Adjuvant Chemotherapy in Early Breast Cancer
Zhejiang Cancer Hospital
Phase NA Unknown
NCT02028494 2018-09-07
CAP7/7
Latin American & Caribbean Society of Medical Oncology
Phase NA Unknown
NCT03042000 2017-02-03
Multicenter, Prospective, RCT：Investigation of Combined Modality Therapy for Locally Advanced Mid/Low Rectal Cancer.
Peking Union Medical College Hospital
Phase NA Unknown
NCT02597868 2016-03-29
A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep)
Zhejiang Cancer Hospital
Phase NA Unknown
NCT02043821 2014-01-24
Maintenance Chemotherapy for Metastatic Colorectal Carcinoma and Biological Marker
Beijing Chao Yang Hospital
Phase NA Unknown
NCT00577057 2013-08-22
Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer
Hospital Authority, Hong Kong
Phase NA Unknown
NCT01549795 2012-07-18
Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy
Azienda Ospedaliera di Padova
Phase NA Unknown